contribute to the hydrophilic character of mucins in mucosal tissues. This study was conducted to identify the repertoire of O-glycans in the tear film and the glycosyltransferases associated with their biosynthesis, in normal subjects and patients with nonSjögren's dry eye. METHODS. Human tear fluid was collected from the inferior conjunctival fornix. O-glycans were released by hydrazinolysis, labeled with 2-aminobenzamide, and analyzed by fluorometric, high-performance liquid chromatography (HPLC) coupled with exoglycosidase digestions. O-glycan structures identified in tears were related to potential biosynthetic pathways in human conjunctival epithelium by using a glycogene microarray database. Lectin-binding analyses were performed with agglutinins from Arachis hypogaea, Maackia amurensis, and Sambucus nigra. RESULTS. The O-glycan profile of human tears consisted primarily of core 1 (Gal␤1-3GalNAc␣1-Ser/Thr)-based structures. Mono-sialyl O-glycans represented approximately 66% of the glycan pool, with ␣2-6-sialyl core 1 being the predominant O-glycan structure in human tears (48%). Four families of glycosyltransferases potentially related to the biosynthesis of these structures were identified in human conjunctiva. These included 13 polypeptide-GalNAc-transferases (GALNT), the core 1 ␤-3-galactosyltransferase (T-synthase), three ␣2-6-sialyltransferases (ST6GalNAc), and two ␣2-3-sialyltransferases (ST3Gal). No significant differences in total amount of O-glycans were detected between tears of normal subjects and patients with dry eye, by HPLC and lectin blot. Likewise, no differences in glycosyltransferase expression were found by glycogene microarray. CONCLUSIONS. This study identified the most common mucintype O-glycans in human tears and their expected biosynthetic pathways in ocular surface epithelia. Patients with nonSjögren's dry eye showed no alterations in composition and amount of O-glycans in the tear fluid. (Invest Ophthalmol Vis Sci. 2009;50:4581-4587)
T he tear film covering the ocular surface epithelia consists of two distinct layers: an outer lipid layer produced primarily by meibomian glands, and an inner layer containing a mixture of mucin and lacrimal fluid, adjacent to the glycocalyx of apical epithelial cells. 1 The mucin component of the tear film contains both secreted and cell-surface-associated mucins, 2 the latter being constitutively shed from the apical glycocalyx of the ocular surface epithelia. The goblet-cell-specific MUC5AC is the major secreted mucin in tears, whereas MUC1, -4, and -16 constitute the major cell-surface-associated mucins. 2 Structurally, both types of mucins are large and very densely glycosylated proteins. O-glycosylation is the predominant posttranscriptional modification of mucins, conferring on them unique physicochemical properties essential for their functions on the ocular surface. These functions include hydrophilicity and an antiadhesive property that provide boundary lubrication and protection against pathogen invasion.
3-5 Mucintype O-linked glycosylation is initiated by a family of enzymes known as UDP-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyltransferases (GALNT) that transfer ␣-N-acetylgalactosamine (GalNAc) to Ser/Thr residues in the protein backbone to form the Tn-antigen. The Tn-antigen can be elongated by other glycosyltransferases to generate a series of inner core O-linked glycans. To date, eight different core structures have been described, with core 1 (Gal␤1-3GalNAc␣1-Ser/Thr), synthesized by core 1 ␤-3-galactosyltransferase (T-synthase), being among the most common in mucins. 6 Core structures can be further modified by addition of other carbohydrates, such as poly-lactosamine, and may be terminated by blood group or tissue antigens, or by sialic acid and sulfate. The composition and sequence of carbohydrates in the mucin Oglycan chain is governed by cell type and tissue-specific expression of mucin-type glycosyltransferases. Recent work by Royle et al. 7 has elegantly demonstrated the structure of mucin O-glycans isolated from conjunctival tissue, but the detailed nature of mucin O-glycans in tears (where they may interact with lectin-like proteins or microorganisms) and the glycosyltransferases associated with their biosynthesis remain mostly uncharacterized.
Altered mucin O-glycosylation has been frequently observed with several pathologies, including Tn syndrome, IgA nephropathy, cystic fibrosis, inflammatory bowel disease, and cancer. 8 -12 In the eye, several reports have described alterations in the carbohydrate composition of the apical glycocalyx of conjunctival epithelial cells in patients with dry eye. These include a reduction in lectin and antibody binding to cell surface carbohydrate epitopes such as sialic acid and core 1, and alteration in the distribution of glycosyltransferases involved in mucin-type O-glycosylation. [13] [14] [15] [16] [17] As determined by rose bengal staining, alteration in cell surface mucin O-glycosylation in aqueous-deficient dry eye correlates with epithelial damage at the ocular surface. 15 It remains unknown, however, whether the O-glycosylation of tear film mucins is altered in dry eye and if so, whether it contributes to an increased susceptibility to ocular surface damage. This study was designed to determine the profile of O-glycans in the human tear film and to analyze the expression of mucin-type O-glycosyltransferases involved in their biosynthesis in normal subjects and patients with dry eye.
MATERIALS AND METHODS

Subject Selection
This study was performed in accordance with the Declaration of Helsinki and the Schepens's Institutional Review Board. Informed consent was obtained from all participants. All prospective subjects completed an institutional review board-approved questionnaire regarding the presence, type, and frequency of their dry eye symptoms.
Two groups of subjects were studied and included individuals in whom the expression of glycogene mRNA at the ocular surface epithelia has been analyzed. 18 The first group consisted of nine normal subjects (seven women and two men) with an age range between 30 and 55 years (average, 40 Ϯ 10), who had no dry eye symptoms, no eye diseases, and no history of eye surgery or contact lens wear. The second group consisted of eight patients (seven women and 1 man) with an age range between 30 and 55 years (average, 41 Ϯ 9), who fit the inclusion criteria for non-Sjögren's dry eye: moderate to severe dry eye symptoms, a Schirmer I reading of less than 8 mm without anesthesia, a tear breakup time of less than 5 seconds, and positive corneal and conjunctival staining with rose bengal. None of the study subjects was receiving topical or systemic medications, and none had a history of ocular surgery and/or contact lens wear, ocular allergies, diabetes, Sjögren's syndrome, or other autoimmune diseases. Subjects primarily included women, who are known to have a higher prevalence of dry eye. 19 All subjects were blood type O to avoid variation in terminal glycosylation.
20,21
Sample Collection
Tear fluid and conjunctival epithelium were collected from normal subjects and patients with non-Sjögren's dry eye, according to a published method. 22 Briefly, tear washes were collected from the inferior fornix of each eye by micropipette after instillation of 60 L of sterile saline onto the unanesthetized ocular surface. Tear samples were centrifuged for 30 minutes at 14,000 rpm at 4°C, and the protein concentration was determined with a protein assay reagent kit (MicroBCA; Pierce, Rockford, IL). A drop of topical anesthetic (0.5% proparacaine HCl, Alcaine; Alcon, Inc., Fort Worth, TX) was then applied to the eye. A sterile disc of nitrocellulose filter paper 10 mm in diameter was placed on the temporal bulbar conjunctiva for 15 seconds, and the disc was carefully transferred into a tube (Eppendorf, Fremont, CA) containing RNA extraction reagent (TRIzol; InvitrogenGibco, Grand Island, NY). Conjunctival RNA was used in a parallel study to determine the overall expression of glycogenes in the human conjunctival epithelium by microarray. 18 For a complete list of glycogenes expressed in the conjunctival epithelium of normal subjects and patients with non-Sjögren's dry eye, view the Functional Glycomics Gateway database (http://www.functionalglycomics.org/glycomics/ publicdata/microarray.jsp/, ref. MAEXP_310_052307; provided in the public domain by the Consortium for Functional Glycomics in cooperation with the Nature Publishing Group, London, UK).
Release of O-glycans by Hydrazinolysis and Fluorescent Labeling
The soluble fractions of tear samples after centrifugation were pooled in groups to allow detection by fluorometric, high-performance liquid chromatography (HPLC). These included two normal groups, containing protein pooled from four and five subjects, and two dry eye groups, containing protein pooled from four subjects each. Tear samples (300 g of total protein) and bovine fetuin (1 mg; Sigma-Aldrich, St. Louis, MO) in reaction vials were lyophilized for 24 hours. Hydrazinolysis was performed with a glycan hydrazinolysis kit (GlycoRelease; Prozyme, San Leandro, CA). Briefly, O-glycans were released by incubation at 60°C for 6 hours with anhydrous hydrazine. Excess hydrazine was removed by evaporation, and the released O-glycans were re-N-acetylated and separated from peptide-derived material by using a solidphase extraction cartridge (Glycoclean R cartridges; Prozyme). The samples were then eluted in water and lyophilized before labeling.
O-glycans were fluorescently labeled with 2-aminobenzamide (2-AB) with a labeling kit (Signal 2-AB; Prozyme). Briefly, released Oglycans were dissolved in 5 L of a freshly prepared solution containing 5 mg 2-AB and 6 mg sodium cyanoborohydride in 150 L acetic acid and 350 L dimethyl sulfoxide. The mixture was incubated at 65°C for 3 hours in a heating block. For subsequent analysis by HPLC, excess dye and other labeling reagents were removed with a cartridge for cleanup of fluorescently labeled glycans (Glycoclean S cartridge; Prozyme). The 2-AB-labeled O-glycans were eluted in water, lyophilized, and stored wrapped in foil at Ϫ20°C until analysis.
Fluorometric HPLC Analysis
2-AB-labeled O-glycans were analyzed by fluorometric normal-phase HPLC using an NH 2 analytical column (4.6 ϫ 250 mm; Zorbax; Agilent Technologies, Palo Alto, CA) connected to a chromatography system (Bio-LC; Dionex Corp., Sunnyvale, CA). Samples were eluted in 50 mM formic acid (pH 4.4) and acetonitrile, in gradient conditions previously described. 23 The total amount of O-glycans in normal and dry eye samples was expressed in picomoles after normalization of fluorescence intensity values to those obtained for a 2-AB-labeled core 1 O-glycan standard (Prozyme).
Exoglycosidase Digestions
2-AB-labeled O-glycans were subject to exoglycosidase digestion with 1 U/mL ␣2-3-sialidase from Streptococcus pneumoniae (NAN1; Prozyme) and 1.5 U/mL ␣2-3,6,8-sialidase from Arthrobacter ureafaciens (ABS; Prozyme). Digestions were performed in 50 mM sodium phosphate (pH 6.0), for 16 hours at 37°C. To remove enzymes before HPLC analyses, samples were passed through protein-binding filters (Micropure-EZ; Millipore, Bedford, MA).
Lectin Blot Analysis
Tear fluid (7.5 g of total protein) was diluted in Laemmli buffer and separated by 1% (wt/vol) agarose gel electrophoresis, as described by Thornton et al. 24 For lectin blot, the proteins were transferred to nitrocellulose membranes (Millipore) by vacuum. The membranes were then blocked with 1% polyvinylpyrrolidone in 0.1% Tween-Trisbuffered saline (pH 7.5), for 1 hour, and incubated with biotin-labeled peanut agglutinin (PNA, 25 g/mL) to the mucin-associated T-antigen epitope, Sambucus nigra agglutinin (SNA, 100 g/mL) to terminal ␣2-6 sialic acid, and Maackia amurensis agglutinin (MAA, 100 g/mL) to terminal ␣2-3 sialic acid for 1.5 hours at room temperature. Membranes were developed with an ABC kit (Vectastain; Vector Laboratories, Burlingame, CA), and lectin binding was visualized with chemiluminescence (SuperSignal West Pico; Pierce). Films were scanned and densitometric analysis was performed with image-analysis software (Digital Science 1D; Eastman Kodak, New Haven, CT).
Statistical Analysis
Statistical comparisons of HPLC data were performed with commercial software (InStat3 software; GraphPad Software, La Jolla, CA). P-values were determined using the unpaired t-test with Welch correction. For microarray data, statistical comparisons were performed using analysis of variance (ANOVA). P Ͻ 0.05 was considered statistically significant.
RESULTS
Identification of Mucin-type O-glycans in Normal Tear Fluid
Mucin-type O-glycans in normal tear fluid were fluorescently labeled and analyzed by normal-phase fluorometric HPLC (Fig.  1) . The identity of each O-glycan structure in the chromatographic profile was assigned by comparison to retention times of the core 1 standard and O-glycans derived from bovine fetuin. Three major O-glycan structures were detected in normal tear film and included core 1 (Gal␤1-3GalNAc), ␣2-6 sialyl 4582 Guzman-Aranguez et al.
IOVS, October 2009, Vol. 50, No. 10 core 1 (Gal␤1-3[NeuNAc␣2-6]GalNAc), and ␣2-3 sialyl core 1 (NeuNAc␣2-3Gal␤1-3GalNAc). In addition to these structures, ␣2-3 sialyl galactose (NeuNAc␣2-3Gal), a peeling product from the ␣2-3 sialyl core 1, 7 was also detected. Analyses of the relative amounts of structures revealed that monosialylated core 1 constituted 66% of the O-glycan pool in tears. ␣2-6 Sialyl core 1 was the most abundant O-glycan in tears (48%), followed by core 1 (16%), ␣2-3 sialyl galactose (10%), and ␣2-3 sialyl core 1 (8%).
The identities of the different structures in the chromatogram were further confirmed by exoglycosidase digestions (Fig. 1) . The NAN1 sialidase, specific for ␣2-3 sialic acid linkages, hydrolyzed the ␣2-3 sialyl core 1 structure to yield core 1 alone. Similarly, the peeling product ␣2-3 sialyl galactose was also hydrolyzed after NAN1 treatment. The ␣2-6 sialyl core 1, on the other hand, was resistant to NAN1, but was cleaved by ABS, a generic sialidase that removes ␣2-3,6,8-linked sialic acids (␣2-8 sialic acids are not found in monosialylated structures, but mainly in di-or tri-sialylated O-glycans 25 ).
Pathways of Mucin O-glycosylation at the Ocular Surface
Analyses of the O-glycan profile in normal tears provided the basis for delineating the pathways of mucin-type O-glycosylation at the ocular surface epithelia, taking advantage of public data on the expression of glycosyltransferases identified by glycogene microarray in conjunctival epithelium. Four families of glycosyltransferases potentially associated with the biosynthesis of O-glycan structures identified in normal tears were detected in human conjunctiva (Fig. 2) . These included 13 UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases (GALNT1 to -8, -10 to -12, -14 and -20), the core 1 ␤-3-galactosyltransferase (core 1 ␤3Gal-T or T-synthase), three ␣2-6-sialyltransferases (ST6GalNAc-I, II, and IV) and two ␣2-3-sialyltransferases (ST3Gal-I and IV). In addition to these, six additional sialic acid glycosyltranfersases were detected by microarray; three ␣2-6-sialyltransferases (ST6GalNAc-III, V, and VI), and three ␣2-3-sialyltransferases (ST3Gal-III, V, and VI). However, acceptor substrate specificity assays have shown that these transferases act preferentially to nonmucin substrates. 26, 27 In addition to the O-glycan structures detected in tear fluid in the present study, a recent report showed core 2 (Gal␤1-3(GlcNAc␤1-6)GalNAc) O-glycans in protein extracts from human conjunctival epithelium. 7 Core 2 is synthesized by ␤1,6 N-acetylglucosaminyltransferases acting on core 1. Analysis of the microarray data revealed two enzymes with ␤1,6 N-acetylglucosaminyltransferase activity in conjunctiva: the mucin-type core 2 ␤1,6 N-acetylglucosaminyltransferase (C2GnT-M), and the I-branching ␤1,6 N-acetylglucosaminyltransferase. C2GnT-M is implicated in the formation of core 2, core 4, and the blood group I structure, whereas the I-branching transferase catalyzes the formation of blood group I. 28 -31 Since blood group I was not detected on mucin-type O-glycans from human conjunctival epithelium or tear fluid, the I-branching transferase was not included as a component in the proposed pathways of mucin-type Oglycosylation at the ocular surface (Fig. 2) . 
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Mucin-type O-glycosylation in Patients with Dry Eye
By fluorometric HPLC, the chromatographic profile of O-glycans from tear samples of patients with dry eye was similar to that from normal subjects: core 1 and monosialylated core 1 O-glycans were detected in the chromatograms from both normal and dry eye samples (data not shown). Quantitative analysis revealed no differences in the amount of core 1 structures between both groups (Fig. 3) . In these experiments, ␣2-3 sialyl core 1 exhibited a downward trend in dry eye, but the difference was not statistically significant. Lack of alteration of glycan structures in the tear fluid of patients with dry eye was further confirmed by lectin blot after separation of the tear proteins in agarose gels (Fig. 4) . These analyses revealed several bands with different electrophoretic mobilities, which correspond to different glycoproteins present in human tear fluid. In normal samples, PNA bound to core 1 structures on a high-molecular-weight band that exhibited an electrophoretic migration typical of mucins (Ͼ250 kDa). Binding to low-molecular-weight glycoproteins was also detected and could correspond to proteolytically degraded mucins or to other O-linked glycoproteins present in tear fluid. PNA binding in non-Sjögren's dry eye samples was comparable in both mobility and intensity to that observed in normal samples (Fig. 4) . SNA and MAA also revealed the presence of several bands corresponding to tear glycoproteins carrying either individual or combined ␣2-3 and ␣2-6 sialic acid-terminated glycans. SNA and MAA can recognize sialic acid epitopes in both N-glycans and O-glycans, compared with PNA, which primarily recognizes O-glycans. The mobility and intensity of the SNA and MAA bands was comparable in normal and dry eye samples.
The expression of glycosyltransferases in the conjunctival epithelium of patients with dry eye was analyzed with a microarray database, as reported in the Materials and Methods section. As shown in Table 1 , no significant differences were observed in the overall expression of glycosyltransferases associated with the biosynthesis of O-glycan structures identified in the tear fluid of normal subjects and those with dry eye.
DISCUSSION
Mucin-type O-glycans have been ascribed multiple functions in mucosal secretions, which include hydration and protection of underlying epithelial cells, providing resistance to protease degradation, and trapping and removing bacteria via specific receptor sites within the O-glycan chains of the mucin. 32 In this study, we have determined the structure and relative amounts of mucin-type O-glycans in human tear fluid, as well as expression of glycosyltransferases involved in their biosynthesis in conjunctival epithelium, in normal subjects, and in patients with non-Sjögren's dry eye.
Our findings on the composition of O-glycans in human normal tears are comparable to those reported recently by Royle et al. 7 on human mucins extracted from human conjunctival tissue; core 1-based structures are the major mucin-type O-glycans at the ocular surface. It is of interest, however, to note three major differences between tissue-associated O-glycans in conjunctiva and those found in tears. First, the conjunctival epithelium contains core 2-based structures, including galactosyl core 2 and di ␣2-3 sialyl galactosyl core 2. Second, ␣2-3 sialyl core 1 is the predominant O-glycan in human conjunctival tissue (47.4%), whereas in tears the prominent O-glycan is ␣2-6 sialyl core 1 (48%). And third, disialyl core 1 is present in conjunctival mucin but not in tears. These 4. Lectin binding to glycoproteins in tear fluid of normal subjects and patients with dry eye. Samples containing 7.5 g of total protein were separated by 1% agarose gel electrophoresis and blotted to nitrocellulose membranes. Glycan content was assessed with biotinlabeled PNA to the mucin-associated T-antigen epitope, SNA to terminal ␣2-6 sialic acid, and MAA to terminal ␣2-3 sialic acid. Left: position of the molecular weight markers. As determined by densitometry (bottom), no differences in lectin binding were detected between tear samples from normal subjects and patients with dry eye. evaluated O-linked glycans in high-molecular-weight fractions of mucin isolates (representing nondegraded mucin) from conjunctival tissue, whereas our study included all O-linked glycans in tears. Second, differences in cellular trafficking may influence the O-glycosylation profiles in mucins. Engelmann et al. 33 have shown that breast cancer epithelial cells transfected with membrane-bound and secretory-recombinant MUC1 produce a transmembrane form that contains mainly sialylated core 1 structures and a secreted form containing predominantly neutral core 2 O-glycans. Third, it is also possible that specific mucin-type O-glycans in conjunctival tissue are associated with intracellular or cell surface glycoproteins and, therefore, are not secreted into the tear film. And fourth, it is possible that the difference in O-glycan composition between conjunctival epithelium and tear film is due to degradation by glycosidase activity in tears (Matthews E, et al. IOVS 2001;42: ARVO Abstract 1432). 34 It is exciting to speculate that the different O-glycan composition observed in epithelial cells and tear fluid confers on mucins unique roles at specific sites. For example, tear mucin bearing ␣2-6 sialyl core 1 could compete for binding to Pseudomonas aeruginosa pili and, therefore, prevent bacterial attachment to ␣2-6 sialyl receptors present on the corneal epithelial surface. 35, 36 Analysis of a microarray database of human conjunctival epithelium allowed us to propose potential pathways for mucin-type O-glycosylation at the ocular surface. Enzymes involved in the initiation of mucin-type O-glycosylation in human conjunctiva included 13 GALNT isoforms (GALNT1 to 8, -10 to -12, -14, and -20) . A previous study using real-time RT-PCR (Taqman; Invitrogen) revealed 15 isoforms in human conjunctiva. 37 These included, in addition to those reported in this study (with the exception of GALNT20, which was not evaluated previously), GALNT15, and low levels of GALNT9 and -13. Data quality parameters, such as background-to-noise ratios, could be responsible for the lack of correlation in the expression of GALNT9, -13, and -15 between the two methods. 38 In addition to GALNT, six ␣2-6 sialyltransferases (ST6GalNAc-I, -II, -III, -IV, -V, and -VI) and five ␣2-3 sialyltransferases (ST3Gal-I, -III, -IV, -V, and -VI) were identified by microarray. In vitro analysis of substrate specificity has revealed, however, that not all sialyltransferases act on mucin-type substrates. ST6GalNAc-I, -II, and -IV mediate the transfer of sialic acid with an ␣2-6-linkage to GalNAc residues O-glycosidically attached to Ser/ Thr, whereas ST6GalNAc-III, -V, and -VI catalyze the addition of sialic acid residues onto gangliosides. 26 As for the ␣2-3 sialyltransferases, ST3Gal-I and -IV have been shown to act on Gal␤1-3GalNAc present on glycoproteins and glycolipids, 39, 40 therefore, constituting potential candidates to synthesize ␣2-3 sialyl core 1 in conjunctival mucin. By contrast, ST3Gal-III exhibits preference for Gal␤1-3GlcNAc structures 41 ; the ST3Gal-VI mainly uses Gal␤1-4GlcNAc as an acceptor substrate 42 ; and the ST3Gal-V only acts on glycolipids. 27 Enzymatic assays using suitable substrates for the glycosyltransferases identified in this study would provide valuable information toward further characterization of the acceptor specificity and kinetic mechanisms of these enzymes.
In several studies, the expression of carbohydrate epitopes has been evaluated in dry eye, both in the tear fluid and the ocular surface epithelial glycocalyx. Using HPLC and the CA 19-9 ELISA test, Garcher et al. 43 and Nakamura et al. 44 have shown a decrease in sialic acid and sialyl-Le a in the tear fluid of patients with dry eye. This decrease, however, could be attributed to changes to glycolipids and N-linked glycans present in the tear film; no sialyl-Le a was detected in our analysis of tear O-glycans or in conjunctival mucin O-glycans. 7 In our hands, no changes were detected by HPLC in the total amount of mucin O-glycans in tears of patients with dry eye. Similarly, no differences were detected in PNA, SNA, and MAA binding to tear glycoproteins in dry eye, indicating lack of alterations in core 1 O-glycosylation and glycoprotein sialylation in the disease. In the epithelial glycocalyx, several authors have reported changes in the distribution of mucin-associated O-glycans. These included alteration in (1) core 1, as determined by PNA staining 16 ; (2) O-acetyl sialylation on MUC16, as determined by H185 antibody binding 13, 15, 17 ; and (3) sialylation of MUC1, as determined by KL-6 antibody staining. 45 These alterations in distribution suggest a compensatory attempt by the ocular surface epithelium to preserve a wet-surfaced phenotype in dry eye by modifying mucin-type O-glycosylation on membrane- Expression values represent the geometric mean of intensities corresponding to nine normal subjects and nine patients with dry eye, as described by Mantelli et al. 18 
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associated mucins on the epithelial glycocalyx. Our results suggest that these alterations in carbohydrate distribution on the epithelial glycocalyx in dry eye do not result in major changes in O-glycan composition and amount in the tears of these patients. We sought to identify genes with altered expression in patients with dry eye by analyzing microarray data from conjunctival samples collected by impression cytology. The results revealed no differences in mRNA expression of mucin-type glycosyltransferases between normal subjects and patients with dry eye. These results are in agreement with those obtained by Imbert et al., 37 by real-time RT-PCR, showing no alterations in GALNT expression in conjunctival epithelium harvested by brush cytology in patients with aqueous-deficient dry eye. In these studies, however, the conjunctiva-stratified epithelium containing both goblet and non-goblet cells-was homogenized previous to analysis. Using immunofluorescence, our laboratory has reported changes in the cell-type and celllayer distribution of GALNT in pathologically keratinized conjunctival epithelia.
14 Although no localization studies have been performed with other mucin-type glycosyltransferases, we hypothesize that alteration in the local distribution of these enzymes, not in their overall expression, might correlate with altered cell surface O-glycosylation and epithelial damage.
In summary, this study provides data on the composition of mucin-type O-glycans in human tear film and on the expression of mucin-type O-glycosyltransferases associated with their biosynthesis in conjunctival epithelium. Using a combination of techniques that included HPLC, lectin-blot, and glycogene microarray analysis, we found no detectable differences in mucintype O-glycosylation in tears or in mucin-type O-glycosyltransferase expression in conjunctiva between patients with nonSjögren's dry eye and normal subjects.
